Abstract
The impact of changing anatomy due to tumour shrinkage was assessed for a VMAT head & neck plan optimized according to our centre’s planning protocol. A custom-built wax phantom accommodating ion chamber, MOSFET, EBT3 film and Fricke-xylenol orange-gelatin (FXG) gel dosimeters and a variable size bolus ‘tumour’ was used in the investigation. Results indicate that the practice of initiating a patient re-scan and verification plan is appropriate when a change in external body contour greater than 1 cm compared to the original anatomy is observed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
